LNC Bio Decides to Issue 11.6 Billion KRW Convertible Bonds Through Subsidiary
[Asia Economy Reporter Lee Seon-ae] LNC Bio announced on the 24th that its subsidiary, Global Medical Research Center, has decided to issue the 3rd series of anonymous, interest-bearing, unsecured private exchangeable bonds worth 11.593 billion KRW to raise operating funds.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- [Breaking] Two Days Before Strike... Central Labor Relations Commission Chair Park Soogeun Says "Differences Narrowing... Possibility of Agreement"
- "Steady 1 Million Won a Month"...National Pension Recipients Surpass 1.1 Million
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
The exchange target is 386,432 registered common shares of LNC Bio Co., Ltd. The exchange ratio is 100%, and the exchange price is 30,000 KRW per share. The exchange request period is from September 14 to July 26, 2025.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
